Literature DB >> 26401194

Are Improvements in Cognitive Content and Depressive Symptoms Correlates or Mediators during Acute-Phase Cognitive Therapy for Recurrent Major Depressive Disorder?

Jeffrey R Vittengl1, Lee Anna Clark2, Michael E Thase3, Robin B Jarrett4.   

Abstract

The cognitive model of depression posits that cognitive therapy's (CT) effect on depressive symptoms is mediated by changes in cognitive content (e.g., automatic negative thoughts dysfunctional attitudes, failure attributions). We tested improvement and normalization of cognitive content among outpatients (N = 523) with recurrent major depressive disorder treated with acute-phase CT (Jarrett & Thase, 2010; Jarrett et al., 2013). We also tested whether improvement in cognitive content accounted for subsequent changes in depressive symptoms and vice versa. Five measures of content improved substantively from pre- to post-CT (median d = 0.96), and the proportions of patients scoring in "healthy" ranges increased (median 45% to 82%). Evidence for cognitive mediation of symptom reduction was limited (median r = .06), as was evidence for symptom mediation of cognitive content improvement (median r = .07). We discuss measurement and design issues relevant to detection of mediators and consider alternative theories of change.

Entities:  

Keywords:  cognitive content; cognitive therapy; major depressive disorder; mediation

Year:  2014        PMID: 26401194      PMCID: PMC4577061          DOI: 10.1521/ijct.2014.7.3.251

Source DB:  PubMed          Journal:  Int J Cogn Ther        ISSN: 1937-1209


  46 in total

Review 1.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

2.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

3.  Mediation analysis.

Authors:  David P MacKinnon; Amanda J Fairchild; Matthew S Fritz
Journal:  Annu Rev Psychol       Date:  2007       Impact factor: 24.137

4.  Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.

Authors:  Robin B Jarrett; Abu Minhajuddin; Howard Gershenfeld; Edward S Friedman; Michael E Thase
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  Change in psychosocial functioning and depressive symptoms during acute-phase cognitive therapy for depression.

Authors:  T W Dunn; J R Vittengl; L A Clark; T Carmody; M E Thase; R B Jarrett
Journal:  Psychol Med       Date:  2011-07-25       Impact factor: 7.723

7.  Cognitive processing of emotional information in depression, panic, and somatoform disorder.

Authors:  Seung-Lark Lim; Ji-Hae Kim
Journal:  J Abnorm Psychol       Date:  2005-02

8.  Validity of sudden gains in acute phase treatment of depression.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Robin B Jarrett
Journal:  J Consult Clin Psychol       Date:  2005-02

9.  The Inventory for Depressive Symptomatology (IDS): preliminary findings.

Authors:  A J Rush; D E Giles; M A Schlesser; C L Fulton; J Weissenburger; C Burns
Journal:  Psychiatry Res       Date:  1986-05       Impact factor: 3.222

10.  Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation.

Authors:  A T Beck; R A Steer; M Kovacs; B Garrison
Journal:  Am J Psychiatry       Date:  1985-05       Impact factor: 18.112

View more
  8 in total

1.  Mechanisms of change in cognitive therapy for major depressive disorder in the community mental health setting.

Authors:  Paul Crits-Christoph; Robert Gallop; Caroline K Diehl; Seohyun Yin; Mary Beth Connolly Gibbons
Journal:  J Consult Clin Psychol       Date:  2017-04-13

2.  The Role of Dyadic Discord in Outcomes in Acute Phase Cognitive Therapy for Adults With Recurrent Major Depressive Disorder.

Authors:  Joseph M Trombello; Jeffrey R Vittengl; Wayne H Denton; Abu Minhajuddin; Michael E Thase; Robin B Jarrett
Journal:  Behav Ther       Date:  2018-12-06

3.  Applying experimental therapeutics to examine cognitive and chronological vulnerabilities as mediators of acute outcomes in cognitive-behavioral therapy and light therapy for winter depression.

Authors:  Kelly J Rohan; Keith B Burt; Julia Camuso; Jessica Perez; Jonah Meyerhoff
Journal:  J Consult Clin Psychol       Date:  2020-08

4.  Improved cognitive content endures for 2 years among unstable responders to acute-phase cognitive therapy for recurrent major depressive disorder.

Authors:  J R Vittengl; L A Clark; M E Thase; R B Jarrett
Journal:  Psychol Med       Date:  2015-06-22       Impact factor: 7.723

5.  Does Symptom Linkage Density Predict Outcomes in Cognitive Therapy for Recurrent Depression?

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase; Robin B Jarrett
Journal:  J Psychopathol Behav Assess       Date:  2021-08-17

6.  Understanding and misunderstanding randomized controlled trials.

Authors:  Angus Deaton; Nancy Cartwright
Journal:  Soc Sci Med       Date:  2017-12-25       Impact factor: 5.379

Review 7.  Addressing heterogeneity (and homogeneity) in treatment mechanisms in depression and the potential to develop diagnostic and predictive biomarkers.

Authors:  Cynthia H Y Fu; Yong Fan; Christos Davatzikos
Journal:  Neuroimage Clin       Date:  2019-08-28       Impact factor: 4.881

8.  Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting: study protocol of the OPTIMA-RCT.

Authors:  Johannes Kopf-Beck; Petra Zimmermann; Samy Egli; Martin Rein; Nils Kappelmann; Julia Fietz; Jeanette Tamm; Katharina Rek; Susanne Lucae; Anna-Katharine Brem; Philipp Sämann; Leonhard Schilbach; Martin E Keck
Journal:  BMC Psychiatry       Date:  2020-10-14       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.